References
1. Frøen JF, Gardosi JO, Thurmann A, Francis A, Stray-Pedersen B. Restricted fetal growth in sudden intrauterine unexplained death. Acta obstetricia et gynecologica Scandinavica. 2004 Sep;83(9):801-7.
2. ACOG. ACOG Practice Bulletin No. 204: Fetal Growth Restriction. Obstetrics and gynecology. 2019 Feb;133(2):e97-e109.
3. Martins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine (SMFM) Consult Series #52: Diagnosis and Management of Fetal Growth Restriction. American journal of obstetrics and gynecology. 2020 May 12.
4. Sharma D, Shastri S, Sharma P. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects. Clinical medicine insights Pediatrics. 2016;10:67-83.
5. Nassr AA, Abdelmagied AM, Shazly SA. Fetal cerebro-placental ratio and adverse perinatal outcome: systematic review and meta-analysis of the association and diagnostic performance. Journal of perinatal medicine. 2016 Mar;44(2):249-56.
6. Denbow ML, Cox P, Taylor M, Hammal DM, Fisk NM. Placental angioarchitecture in monochorionic twin pregnancies: relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome. American journal of obstetrics and gynecology. 2000 Feb;182(2):417-26.
7. Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, Mondon F, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Human molecular genetics. 2012 May 1;21(9):1968-78.
8. Gascoin-Lachambre G, Buffat C, Rebourcet R, Chelbi ST, Rigourd V, Mondon F, et al. Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta. 2010 Feb;31(2):151-7.
9. Shen K, Moroco JA. The Src family kinase Fgr is a transforming oncoprotein that functions independently of SH3-SH2 domain regulation. 2018 Oct 23;11(553).
10. Verfaille V, de Jonge A, Mokkink L, Westerneng M, van der Horst H, Jellema P, et al. Multidisciplinary consensus on screening for, diagnosis and management of fetal growth restriction in the Netherlands. BMC pregnancy and childbirth. 2017 Oct 16;17(1):353.
11. Tanaka H, Furuhashi FH, Toriyabe K, Matsumoto T, Magawa S, Nii M, et al. Management of fetal growth restriction using the contraction stress test: a case-control study. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2019 Oct;32(19):3221-5.
12. Kidd AC, McGettrick M, Tsim S, Halligan DL, Bylesjo M, Blyth KG. Survival prediction in mesothelioma using a scalable Lasso regression model: instructions for use and initial performance using clinical predictors. BMJ open respiratory research. 2018;5(1):e000240.
13. Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC medical informatics and decision making. 2008 Nov 26;8:53.
14. McCowan LM, Figueras F, Anderson NH. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy. American journal of obstetrics and gynecology. 2018 Feb;218(2s):S855-s68.
15. Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet (London, England). 1986 May 10;1(8489):1077-81.
16. Walker AR, Walker BF. Fetal nutrition and cardiovascular disease in adult life. Lancet (London, England). 1993 May 29;341(8857):1421.
17. Hanson MA, Gluckman PD. Developmental origins of health and disease: new insights. Basic & clinical pharmacology & toxicology. 2008 Feb;102(2):90-3.
18. Haas SA, Oi K. The developmental origins of health and disease in international perspective. Social science & medicine (1982). 2018 Sep;213:123-33.
19. Kesavan K, Devaskar SU. Intrauterine Growth Restriction: Postnatal Monitoring and Outcomes. Pediatric clinics of North America. 2019 Apr;66(2):403-23.
20. Rodger MA, Carrier M, Le Gal G, Martinelli I, Perna A, Rey E, et al. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood. 2014 Feb 6;123(6):822-8.
21. Roberge S, Nicolaides K, Demers S, Hyett J, Chaillet N, Bujold E. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. American journal of obstetrics and gynecology. 2017 Feb;216(2):110-20.e6.
22. Inácio QAS, Araujo Júnior E. Perinatal Outcomes of Fetuses with Early Growth Restriction, Late Growth Restriction, Small for Gestational Age, and Adequate for Gestational Age. 2019 Dec;41(12):688-96.
23. Vayssière C, Sentilhes L, Ego A, Bernard C, Cambourieu D, Flamant C, et al. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. European journal of obstetrics, gynecology, and reproductive biology. 2015 Oct;193:10-8.
24. Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, et al. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2013 Oct;42(4):400-8.
25. Modi N. Time to bring fetal growth assessment into the 21st century. BJOG : an international journal of obstetrics and gynaecology. 2016 Nov;123(12):1989.
26. Lausman A, Kingdom J. Intrauterine growth restriction: screening, diagnosis, and management. Journal of obstetrics and gynaecology Canada : JOGC = Journal d’obstetrique et gynecologie du Canada : JOGC. 2013 Aug;35(8):741-8.
27. Bernardes TP, Broekhuijsen K, Koopmans CM, Boers KE, van Wyk L, Tajik P, et al. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials. BJOG : an international journal of obstetrics and gynaecology. 2016 Aug;123(9):1501-8.
28. Horowitz KM, Feldman D. Fetal growth restriction: risk factors for unplanned primary cesarean delivery. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2015;28(18):2131-4.